Which diabetic patients should receive podiatry care? An objective analysis

Internal Medicine Journal

Volumn 35, Issue 8, 2005, Pages 451-456

  McGill, Marg ^a   Molyneaux, L ^a   Yue, D K ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diabetes; Foot ulceration; High risk foot; Lower limb amputation; Podiatry

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; FOLLOW UP; FOOT AMPUTATION; FOOT ULCER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PODIATRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSATION; SHOE; SURVIVAL RATE; VIBRATION SENSE;

AGE FACTORS; AMPUTATION; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEW SOUTH WALES; PODIATRY; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN CARE; TREATMENT OUTCOME;

EID: 23844446063     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00880.x     Document Type: Article

References (26)

1. Jude EB, Spittle M, Connor H, Boulton AJ. The diabetic foot. Diabetic Med 1999; 16: 170-2.
2. Reiber GE. Lower Extremity Ulcers and Amputation in Diabetes. Diabetes in America. National Institute of Health. NIH Publication No. 95. 1995; 1468.
3. Colaguiri S, Colaguiri R, Ward J. National Diabetes Strategy and Implementation Plan. Canberra: Diabetes Australia; 1998.
4. Connor H. The St Vincent amputation target: the cost of achieving it and the cost of failure. Diabetic Med 1997; 14: 152-3.
5. Williams DRR. The size of the problem: epidemiological and economic aspects of foot problems in diabetes. In: Boulton AJM, Connor H, Cavanagh PR, eds. The Foot in Diabetes, 2nd edn. New York: Wiley; 1994; 15-24.
6. Shearer A, Scuffham P, Gordois A, Oglesby A. Predicted costs of reduced vibration detection in the UK Diabetic Foot 2003; 6: 30-7.
7. Pecoraro RE, Reiber GE, Burgess EM. Causal pathways to amputation: basis for prevention. Diabetes Care 1990; 13: 513-21.
8. McGill M, Molyneaux LM, Yue DK. Use of the Semmes Weinstein 5.07/10 gm monofilament: the long and the short of it Diabetic Med 1998; 15: 615-17.
9. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 10: 452-4.
10. Malone JM, Snyder M, Anderson G, Bernard VM, Holloway GA, Bunt GA Jr. Prevention of amputation by diabetic education. Am J Surg 1989; 158: 520-4.
11. Sowell RD, Mangel WB, Kilczewski CJ, Normington JM. Effect of podiatric medical care on rates of lower-extremity amputation in a medicare population. J Am Podiatr Med Assoc 1999; 89: 312-17.
12. Falkenberg M. Metabolic control and amputations among diabetics in primary health care - a population-based intensified programme governed by patient education. Scand J Prim Health Care 1990; 8: 25-9.
13. Larsson J, Apelqvist J, Agardh CD, Stenstrom A. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabetic Med 1995; 12: 770-6.
14. Fryberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998; 21: 1714-19.
15. Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a mulitidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999; 22: 1428-31.
16. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependant diabetes mellitus: a randomised, controlled trial. Ann Intern Med 1993; 119: 36-41.
17. Chantelau E, Haage P. An audit of cushioned diabetic footwear: relation to patient compliance. Diabetic Med 1993; 11: 114-16.
18. Uccioli L, Faglia E, Monticone G, Favales F, Durola L, Aldeghi A et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995; 18: 1376-8.
19. Moss SE, Klein R, Klein B. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992; 152: 610-15.
20. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med 1992; 117: 97-105.
21. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1990; 13: 1057-61.
22. Boulton AJM, Kubrusly DB, Bowker JH, Gadia MT, Quintero L, Becker DM et al. Impaired vibratory perception and diabetic foot ulceration. Diabetes Care 1986; 3: 335-7.
23. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994; 17: 557-60.
24. Olmos PR, Cataland S, O'Dorisimo TM, Casey C, Simon S. The Semmes Weinstein monofilament as a potential predictor of foot ulceration in patients with non-insulin dependent diabetes. Am J Med Sci 1995; 309: 76-82.
25. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton. AMJ. Semmes Weinstein monofilaments: a simple effective and inexpensive screening device for identifying patients at risk of foot ulceration. Diabetes Res Clin Pract 1991; 13: 63-8.
26. Tapp RJ, Zimmet PZ, Harper CA, de Courten MP. Diabetes care in an Australian population. Diabetes Care: 2004; 27: 688.